Lantheus Holdings Inc (LNTH)
75.53
-2.65
(-3.39%)
USD |
NASDAQ |
May 03, 16:00
75.76
+0.23
(+0.30%)
After-Hours: 20:00
Lantheus Holdings Free Cash Flow: 278.34M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 278.34M |
| December 31, 2023 | 258.70M |
| September 30, 2023 | 259.12M |
| June 30, 2023 | 244.48M |
| March 31, 2023 | 355.69M |
| December 31, 2022 | 263.43M |
| September 30, 2022 | 172.15M |
| June 30, 2022 | 86.59M |
| March 31, 2022 | 41.55M |
| December 31, 2021 | 41.78M |
| September 30, 2021 | 29.22M |
| June 30, 2021 | 32.13M |
| March 31, 2021 | 4.51M |
| December 31, 2020 | 3.922M |
| September 30, 2020 | 24.82M |
| June 30, 2020 | 43.08M |
| March 31, 2020 | 65.12M |
| December 31, 2019 | 58.32M |
| September 30, 2019 | 50.58M |
| June 30, 2019 | 46.75M |
| March 31, 2019 | 43.78M |
| Date | Value |
|---|---|
| December 31, 2018 | 41.06M |
| September 30, 2018 | 38.25M |
| June 30, 2018 | 31.29M |
| March 31, 2018 | 33.81M |
| December 31, 2017 | 37.23M |
| September 30, 2017 | 40.46M |
| June 30, 2017 | 41.01M |
| March 31, 2017 | 40.74M |
| December 31, 2016 | 42.24M |
| September 30, 2016 | 39.78M |
| June 30, 2016 | 30.03M |
| March 31, 2016 | -0.92M |
| December 31, 2015 | 8.611M |
| September 30, 2015 | -5.992M |
| June 30, 2015 | 9.588M |
| March 31, 2015 | 16.65M |
| December 31, 2014 | 3.453M |
| September 30, 2014 | 4.99M |
| June 30, 2014 | -10.32M |
| March 31, 2014 | -20.52M |
| December 31, 2013 | -20.58M |
Free Cash Flow Range, Past 5 Years
3.922M
Minimum
Dec 2020
355.69M
Maximum
Mar 2023
118.01M
Average
54.45M
Median
Free Cash Flow Benchmarks
| Perspective Therapeutics Inc | -37.98M |
| Boston Scientific Corp | 1.553B |
| Align Technology Inc | 491.58M |
| Edwards Lifesciences Corp | 251.20M |
| NeuroMetrix Inc | -6.268M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 127.24M |
| Cash from Investing (Quarterly) | -106.53M |
| Cash from Financing (Quarterly) | -16.84M |
| Free Cash Flow Per Share (Quarterly) | 1.697 |
| Free Cash Flow to Equity (Quarterly) | 118.26M |
| Free Cash Flow to Firm (Quarterly) | 118.96M |
| Free Cash Flow Yield | 5.24% |